Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Institut_Pasteur
|
| gptkbp:appointed_by |
gptkb:hospital
gptkb:Person gptkb:mythological_figure hospitals livestock emergency situations animal shelters research facilities veterinary clinics wild animals zoos clinical settings wildlife conservation programs international health organizations government health programs domestic pets public health clinics |
| gptkbp:brand |
gptkb:Imovax_Rabies
gptkb:Rab_Avert |
| gptkbp:can_be_used_with |
other vaccines
|
| gptkbp:developed_by |
gptkb:Louis_Pasteur
|
| gptkbp:duration |
several years
|
| gptkbp:education_institution |
in public health campaigns
|
| gptkbp:first_introduced |
1885
|
| https://www.w3.org/2000/01/rdf-schema#label |
rabies vaccine
|
| gptkbp:is_available_in |
many countries
|
| gptkbp:is_considered |
a critical vaccine for at-risk populations
essential for certain occupations |
| gptkbp:is_discussed_in |
gptkb:academic_journal
|
| gptkbp:is_effective_against |
high when administered promptly
|
| gptkbp:is_evaluated_by |
safety and efficacy
|
| gptkbp:is_linked_to |
reduction in rabies cases
|
| gptkbp:is_part_of |
public health initiatives
travel health recommendations animal health regulations animal vaccination programs |
| gptkbp:is_promoted_by |
health organizations
|
| gptkbp:is_subject_to |
regulatory approval
|
| gptkbp:is_used_for |
preventing rabies
|
| gptkbp:is_used_in |
research studies
|
| gptkbp:manager |
injection
|
| gptkbp:part_of |
rabies prevention strategy
|
| gptkbp:preceded_by |
potential rabies exposure
travel to high-risk areas |
| gptkbp:produced_by |
various pharmaceutical companies
|
| gptkbp:requires |
certain animal travel
multiple doses for full immunity pet ownership in some regions |
| gptkbp:side_effect |
headache
nausea fever pain at injection site |
| gptkbp:storage |
refrigeration
|
| gptkbp:suitable_for |
veterinarians
wildlife rehabilitators post-exposure prophylaxis people with severe allergic reactions to components pre-exposure prophylaxis |
| gptkbp:type |
inactivated vaccine
|